<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Maravai Lifesciences Holdings Inc — News on 6ix</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc</link>
<description>Latest news and press releases for Maravai Lifesciences Holdings Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 20 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/maravai-lifesciences-holdings-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68359d5978dffbe2df1078c6.webp</url>
<title>Maravai Lifesciences Holdings Inc</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc</link>
</image>
<item>
<title>Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-to-host-earnings-conference-call-on-thursday-may-7-2026</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-to-host-earnings-conference-call-on-thursday-may-7-2026</guid>
<pubDate>Mon, 20 Apr 2026 20:05:00 GMT</pubDate>
<description>SAN DIEGO, April 20, 2026--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2026 financial and operating results after the market close on Thursday, May 7, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.</description>
</item>
<item>
<title>Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-reports-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Wed, 25 Feb 2026 05:00:00 GMT</pubDate>
<description>Organizational restructuring and operating cost reduction ahead of plan Focus on operational excellence, revenue growth, and improving Adjusted EBITDA SAN</description>
</item>
<item>
<title>Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-host-earnings-conference-220500661</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-host-earnings-conference-220500661</guid>
<pubDate>Mon, 09 Feb 2026 22:05:00 GMT</pubDate>
<description>SAN DIEGO, February 09, 2026--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2025 financial and operating results after the market close on Wednesday, February 25, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.</description>
</item>
<item>
<title>Maravai LifeSciences Announces November 2025 Investor Conference Schedule</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-announces-november-2025-investor-conference-schedule-2025-11-10</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-announces-november-2025-investor-conference-schedule-2025-11-10</guid>
<pubDate>Mon, 10 Nov 2025 05:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech</description>
</item>
<item>
<title>Maravai LifeSciences Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-reports-third-quarter-2025-financial-results-2025-11-06</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-reports-third-quarter-2025-financial-results-2025-11-06</guid>
<pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
<description>Organizational restructuring and operating cost reduction initiatives on track SAN DIEGO--(BUSINESS WIRE)-- Maravai LifeSciences Holdings, Inc. (Maravai)</description>
</item>
<item>
<title>Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-host-earnings-conference-call-thursday-november-6-2025-2025-10</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-host-earnings-conference-call-thursday-november-6-2025-2025-10</guid>
<pubDate>Wed, 22 Oct 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and</description>
</item>
<item>
<title>Maravai LifeSciences Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-reports-second-quarter-2025-financial-results-2025-08-11</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-reports-second-quarter-2025-financial-results-2025-08-11</guid>
<pubDate>Mon, 11 Aug 2025 04:00:00 GMT</pubDate>
<description>Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings Quarterly base</description>
</item>
<item>
<title>Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-host-earnings-conference-call-monday-august-11-2025-2025-07-28</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-host-earnings-conference-call-monday-august-11-2025-2025-07-28</guid>
<pubDate>Mon, 28 Jul 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to</description>
</item>
<item>
<title>Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-appoints-rajesh-asarpota-chief-financial-officer-2025-06-25</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-appoints-rajesh-asarpota-chief-financial-officer-2025-06-25</guid>
<pubDate>Wed, 25 Jun 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to</description>
</item>
<item>
<title>Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-appoints-bernd-brust-chief-executive-officer-and-member-its</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-appoints-bernd-brust-chief-executive-officer-and-member-its</guid>
<pubDate>Mon, 09 Jun 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to</description>
</item>
<item>
<title>TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/trilink-biotechnologiesr-and-quantoom-biosciences-sign-license-and-supply-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/trilink-biotechnologiesr-and-quantoom-biosciences-sign-license-and-supply-agreement</guid>
<pubDate>Tue, 03 Jun 2025 04:00:00 GMT</pubDate>
<description>Quantoom’s customers can now access TriLink’s CleanCap mRNA capping technology; Agreement supports future expansion of essential therapeutics & vaccines in</description>
</item>
<item>
<title>CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/correction-maravai-lifesciences-releases-2024-sustainability-report-2025-05-21</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/correction-maravai-lifesciences-releases-2024-sustainability-report-2025-05-21</guid>
<pubDate>Wed, 21 May 2025 04:00:00 GMT</pubDate>
<description>Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas</description>
</item>
<item>
<title>Maravai LifeSciencesReleases 2024 Sustainability Report</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciencesreleases-2024-sustainability-report-2025-05-21</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciencesreleases-2024-sustainability-report-2025-05-21</guid>
<pubDate>Wed, 21 May 2025 04:00:00 GMT</pubDate>
<description>Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas</description>
</item>
<item>
<title>TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/trilink-biotechnologiesr-debuts-its-first-mrna-synthesis-kit-cleancapr-capping</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/trilink-biotechnologiesr-debuts-its-first-mrna-synthesis-kit-cleancapr-capping</guid>
<pubDate>Tue, 20 May 2025 04:00:00 GMT</pubDate>
<description>New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through streamlined mRNA synthesis with</description>
</item>
<item>
<title>TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/trilink-biotechnologiesr-and-international-vaccine-institute-sign-memorandum</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/trilink-biotechnologiesr-and-international-vaccine-institute-sign-memorandum</guid>
<pubDate>Wed, 14 May 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Today, TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science</description>
</item>
<item>
<title>Maravai Lifesciences Reports First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-reports-first-quarter-2025-financial-results-2025-05-12</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-reports-first-quarter-2025-financial-results-2025-05-12</guid>
<pubDate>Mon, 12 May 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents</description>
</item>
<item>
<title>Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-host-earnings-conference-call-monday-may-12-2025-2025-05-01</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-host-earnings-conference-call-monday-may-12-2025-2025-05-01</guid>
<pubDate>Thu, 01 May 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to</description>
</item>
<item>
<title>Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-reports-fourth-quarter-and-full-year-2024-financial-results-2025</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-reports-fourth-quarter-and-full-year-2024-financial-results-2025</guid>
<pubDate>Tue, 18 Mar 2025 04:00:00 GMT</pubDate>
<description>Schedules Conference Call for Thursday, March 20, 2025 SAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:</description>
</item>
<item>
<title>Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-postpones-its-fourth-quarter-and-full-year-2024-earnings-release</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-postpones-its-fourth-quarter-and-full-year-2024-earnings-release</guid>
<pubDate>Tue, 25 Feb 2025 05:00:00 GMT</pubDate>
<description>SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and</description>
</item>
<item>
<title>Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio</title>
<link>https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-completes-acquisition-dna-and-rna-business-officinae-bio-2025-02</link>
<guid isPermaLink="true">https://6ix.com/company/maravai-lifesciences-holdings-inc/news/maravai-lifesciences-completes-acquisition-dna-and-rna-business-officinae-bio-2025-02</guid>
<pubDate>Mon, 24 Feb 2025 05:00:00 GMT</pubDate>
<description>Officinae Bio's AI-driven sequence optimization expands Maravai's family of brands, enabling rapid, cost-effective nucleic acid therapy development SAN</description>
</item>
</channel>
</rss>